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Background: The mechanism of db-cAMP regulating fat deposition and improving lean percentage is unclear and
needs to be further studied.
Methods: Eighteen 100-day-old Duroc × Landrance × Large White barrows (49.75 ± 0.75 kg) were used for
experiment 1, and 15 eighteen 135-day-old barrows (78.34 ± 1.22 kg) were used for experiment 2 to investigate the
effects of dietary dibutyryl-cAMP (db-cAMP) on fat deposition in finishing pigs. Pigs were fed with a corn-soybean
meal-based diet supplemented with 0 or 15 mg/kg db-cAMP, and both experiments lasted 35 days, respectively.
Results: The results showed that db-cAMP decreased the backfat thickness, backfat percentage, and diameter of
backfat cells without changing the growth performance or carcass characteristics in both experiments, and this effect
was more marked in experiment 1 than in experiment 2; db-cAMP enhanced the activity of the growth hormone–
insulin-like growth factor-1 (GH-IGF-1) axis and pro-opiomelanocortin (POMC) system in both experiments, which
suppressed the accumulation of backfat deposition; microarray analysis showed that db-cAMP suppressed the
inflammatory system within the adipose tissue related to insulin sensitivity, which also reduced fat synthesis.
Conclusions: In summary, the effect of db-cAMP on suppressing fat synthesis and accumulation is better in the earlier
phase than in the later phase of finishing pigs, and db-cAMP plays this function by increasing the activity of the GH-IGF-1
axis and POMC system, while decreasing the inflammatory system within the adipose tissue related to insulin sensitive or
lipolysis.
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Dibutyryl cAMP (db-cAMP), an orally active cell-permeant
derivative of cAMP, has the same functions as endogenous
cAMP, the latter playing a crucial role of signal transduc-
tion in numerous biological activities, such as regulating
cell growth, enzyme activities, lipolysis, and gene expression
[31, 38]. In recent years, dietary db-cAMP has been used in
the pig production with beneficial effect on increasing the* Correspondence: jiangz28@qq.com
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[39]. Our previous work [38] also showed that db-cAMP
increased the lean percentage and decreased the backfat
thickness, while it did not affect the growth performance or
meat quality, indicating that db-cAMP may have potential
for producing more lean meat as a feed additive in pig pro-
duction. Some reports indicated that db-cAMP decreased
the size of adipocytes, inhibited fat deposition in adipocytes,
and reduced proliferation and differentiation of the preadi-
pocytes [21, 38]. As cAMP is well-known for many hor-
mones mediating signal transduction, and promoting
lipolysis through adenylyl cyclase-cAMP-protein kinase
pathway [4, 6], it seemed likely that exogenous db-cAMPle is distributed under the terms of the Creative Commons Attribution 4.0
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ing pathway. Exogenous supplementation with cAMP or
db-cAMP to anterior pituitary cells promoted the secretion
of growth hormone [30] which is known to stimulate lean-
tissue growth and inhibit adipose tissue growth [5]. Db-
cAMP also increased the expression of beta-adrenoceptors
and activated endogenous adenylate cyclase [7]. In addition,
cAMP inhibited expression of genes such as fatty acid syn-
thase (FAS) and malate dehydrogenase (MDH) in fat cells
in vitro [11]. However, the mechanism of db-cAMP regulat-
ing fat deposition and improving lean percentage needs to
be further studied. The present research has investigated
the effect of dietary db-cAMP on concentrations of relevant
hormones, metabolic indices, and gene expression profiles
in backfat adipocytes of pigs to better understand the func-
tional mechanisms of its action.
Methods
Pigs and diets
Eighteen 100-day-old Duroc × Landrance × Large White
barrows (49.75 ± 0.75 kg) were used for experiment 1,
and eighteen 135-day-old barrows (78.34 ± 1.22 kg) were
used for experiment 2, each experiment lasting for
35 days and treated at the same condition. Other than
for balancing on the basis of weight and ancestry, pigs
were randomly assigned to 2 groups, controls, or supple-
mented with db-cAMP. Each treatment consisted of
three replicate pens, each with three pigs. All pigs were
housed in the animal facilities of the Institute of Animal
Science in the Guangdong Academy of Agricultural
Sciences. Pigs were fed with a corn-soybean meal-based
diet (Table 1, meeting requirements for finishing pigs
according to NRC (1998), without (as controls) or withTable 1 Composition and nutrient levels of the basal diets for two s
Item Experiment 1 Experiment 2
Corn 67.700 69.300
Soybean 25.900 20.700
Wheat bran 3.645 7.645
Salt 0.370 0.370
Dicalcium Phosphate 0.900 0.600
Limestone 1.000 0.900
Lysine.HCl 0.130 0.130
Mineral mixa 0.100 0.100
Vitamin mixb 0.040 0.040
Chloride choline (50 %) 0.100 0.100
Antimildew agent 0.100 0.100
Antioxidant agent 0.015 0.015
Total 100.00 100.00
asupplied 8 mg Cu (CuSO4.5H2O); 60 mg Fe (FeSO4.7H2O); 60 mg Zn (ZnSO4. H2O); 3
bsupplied 5000 IU vitamin A; 700 IU vitamin D3; 25 mg vitamin E; 2.5 mg vitamin K3
pantothenate; 20 mg niacin; 0.5 mg folic acid; 0.04 mg biotin per kg of diet15 mg/kg db-cAMP (98 % purity, Hangzhou Meiya
Biotechnology Co, Ltd, Hangzhou, China) as described
by Wang et al. [38] (note: experiment 1 stands for the
earlier phase of fattening pigs; experiment 2 stands for
the later phase of fattening pigs).
Feeding and slaughter procedure
Pigs were weighed at the end of the experiment, and feed
consumed was recorded daily for each replicate to deter-
mine average daily gain (ADG), average daily feed intake
(ADFI), and feed to gain (F:G). At the end of each experi-
ment, pigs were fasted for 14 h, blood sampled, then imme-
diately electro-stunned, and exsanguinated. All aspects of
the experiment including transport and slaughtering proce-
dures were carried out in accordance with the Chinese
guidelines [29] and approved by Animal Ethical Committee
of Institute of Animal Science, Guangdong Academy of
Agricultural Sciences. Carcasses were weighed and split in
the median plane. The dressing percentage, lean percent-
age, and fat percentage were measured using one side of
the individual carcass. Backfat thickness was measured on
the midline over the first, tenth, and last rib and cross-
sectional area. The longissimus muscle area was measured
at the junction of thoracic and lumbar vertebrae, by tracing
onto sulfate paper followed by planimetry.
Sample collection
Blood was collected from the anterior vena cava using
vacuum tubes (no anticoagulant), allowed to clot at
room temperature for 120 min, and centrifuged for
5 min at 3000 × g at 4 °C, and serum was stored at −20 °C.
Samples of longissimus muscle over the ninth to tenth ribs
were immediately obtained and frozen in liquid N2 fortages of finishing pigs
Chemical composition Experiment 1 Experiment 2
Digestible energy (MJ/kg) 13.39 13.27
Crude protein (%) 17.04 15.57
Calcium (%) 0.66 0.55
Available energy (%) 0.24 0.19
Lysine (%) 0.97 0.85
Methionine (%) 0.25 0.23
Methionine + cysteine (%) 0.52 0.48
5 mg Mn (MnO); 0.35 mg I (KI ); 0.3 mg Se (NaSeO3) per kg of diet.
; 1.5 mg vitamin B1; 5 mg vitamin B2; 0.02 mg vitamin B12; 7.5 mg calcium
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activities, and messenger RNA (mRNA) analysis, and add-
itional longissimus samples were held at 4 °C for meat
quality measurements. Fresh samples of backfat adipose
tissue (1 cm3) were fixed in 4 % paraformaldehyde in PBS
(pH 7.3) for histology. Liver, pituitary, and hypothalamus
tissue samples also were collected immediately and held,
as described above, for mRNA extraction.
Measurement of hormones and biochemical variables in
plasma
The plasma concentrations of high-density lipoprotein
(HDL), low-density lipoprotein (LDL), free fatty acid (FFA),
cholesterol, and triglyceride (TG) were determined using an
automatic analyzer (cx5, Beckman Coulter INC, Brea, CA),
and the activity of lipase was determined using an ELISA kit
(Luyu Bioengineering, Shanghai, China). The concentrations
of cAMP, GH, IGF-I, IGFBP3, T3, T4, leptin, AD, and insu-
lin were measured using ELISA kits (GBD Co, Ltd, USA).
Meat quality measurements
The pH of muscle samples was measured at 45 min, 24 h,
and 48 h postmortem using a pH meter (HI 8242C, Beijing
Hanna Instruments Science & Technology, Beijing, China).
Drip loss was measured, as described by Ma et al. [17]. Meat
color CIE LAB values (L*, relative lightness; a*, relative red-
ness; b*, relative yellowness) were determined on the trans-
verse surface of the meat sample after it was cut and exposed
to air for 45 min with a colorimeter (CR-410, Minolta,
Suita-shi, Osaka, Japan); Shear force was measured using an
Instron Universal Mechanical Machine (Instron model 4411;
Instron, Canton, MA), as described by Ma et al. [17].
Measurement of intramuscular fat content
The muscle samples were lyophilized and grounded to
powders. The IMF content was measured by petroleum
ether (30 to 60 °C boiling point) extraction using the
Soxtec 2055 fat extraction system (Foss Tecator AB,
Sweden), as described by Ma et al. [17].
Diameter and the density of adipocytes
Fixed tissues were embedded in paraffin, sectioned at 5 -
micrometer (mm), dewaxed, and then stained with
hematoxylin and eosin (Beijing Biosynthesis Biotechnology
Co, Ltd, Beijing, China). The sections (ten sections per
sample) were viewed at ×10 magnification using a Motic
BA400 microscope, and the diameter and density of the ad-
ipocytes were determined with Motic image software
(Motic-Optic Industrial Group Co. Ltd, Xiamen, China).
Gene microarray analysis
Total RNA was isolated from backfat tissue from experi-
ment 1 using TRIzol reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer’s instructions. The qualityand quantity of RNA were assessed by OD260/OD280.
Five micrograms of total RNA was converted to double-
stranded complementary DNA (cDNA) using the RT-kit
(QIAGEN, Shanghai, China) with an oligo (dT) primer
containing a T7 RNA polymerase promoter. Biotin-la-
beled complementary RNA (cRNA) was synthesized
from purified double-stranded cDNA using a Bio-Array
high-yield RNA transcript labeling kit (QIAGEN). Ap-
proximately 20 mg cRNA was fragmented to 50–300
bases and hybridized to Porcine Oligo Microarray chips
(Agilent, Santa Clara, CA). A total of six chips were used
here: three replicates for controls and pigs receiving db-
cAMP (mRNA was pooled for the three pigs each
replicate). The hybridized arrays were washed, stained,
and scanned following the Porcine Oligo Microarray
GeneChip Expression Analysis manual.
Real-time quantitative PCR of selected genes in backfat,
liver, pituitary, and hypothalamus tissue
Total RNA was isolated (as above) from hypothalamus,
pituitary, liver, and backfat tissue and stored at −80 °C.
cDNA was produced using a commercial kit containing
Reverse Transcriptase XL (AMV) and RNAsin (Invitro-
gen). Real-time PCR was performed using an ABI 7500
Mastercycler (Applied Biosystems, Foster City, CA) with
qPCR Mix (TaKaRa, BIOINC, Japan). The gene
(ADCYAP1, GHRH, CRH, POMC, PC1, PC2) expression
levels were determined in hypothalamus tissue; the gene
(GHRHR, GH, CRHR, POMC, TRHR, TSH) expression
levels were determined in pituitary tissue; the gene
(GHR, IGF-1) expression levels were determined in liver
tissue. The selected genes (SAL1, STAR, CYP2A19,
STAT1, SYK, CCL2, AIF1, ITGB2, CCR1 and CXCL2) of
backfat were chosen from the results of the chip analysis
results and beta-actin (reference transcript gene) was de-
signed from the GenBank sequences.
Statistical analysis
Values were expressed as means ± SEM. Data were ana-
lyzed by t tests (Statistical Analysis Software version 8.1;
SAS Institute, Inc, Cary, NC). Base on this, the effects of
db-cAMP in experiments 1 and 2 were reanalyzed using
two-way ANOVA followed by an appropriate post hoc t
test. P values <0.05 were considered to be significant,
and P values <0.01 were considered to be extremely
significant.
Gene chip expression data analysis was performed
using PCA project in the SAS system online. False dis-
covery rate (FDR) correction was applied using the step-
up method. Probe sets that met a FDR value of ≤0.05
and average fold change (FC) of at least 2 in either direc-
tion were selected for further study. The GenMAPP-CS
software package (http://www.genmapp.org) was used
for gene ontology (GO) and pathway analysis.
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Effect of dietary db-cAMP on growth performance and
carcass characteristics
Dietary supplementation with 15 mg/kg db-cAMP did
not affect (P > 0.05) final body weight, ADG, ADFI, or
F:G ratio of the pigs in either experiments (Table 2).
There were no significant effects of treatment on dress-
ing percentage, longissimus muscle area, or lean per-
centage of the pigs in either experiment (Table 2).
Dietary db-cAMP decreased the fat percentage of the
pigs by 16.1 % in experiment 1 (135-day) and 12.1 % in
experiment 2 (170-day) (P < 0.05), it also deceased the
average backfat thickness by 22.4 % in experiment 1 and
by 17.8 % in experiment 2 (P < 0.05), and the differences
were greater in experiment 1 than that in experiment 2
(P < 0.05).
Effect of db-cAMP on meat quality of finishing pigs
There were no differences on meat quality traits (e.g.,
pH value, drip loss, shear force, and meat color) betweenTable 2 Effects of db-cAMP on growth performance, carcass traits a
Variable Experiment 1
Controls
Final weight (kg) 72.24±2.46
Average daily feed intake (kg) 2.32±0.15
Average daily gain (kg) 0.73±0.05
F/G 3.35±0.03
Dressing percentage (%) 73.80±1.25
Longissimus muscle area (cm2) 34.10±2.82
Lean percentage (%) 62.02±1.51





Average backfat thickness# 2.32±0.15
Drop loss (%) (24 h) 2.42±0.10
Intramuscular fat (%) 2.01±0.34
Shear force (48 h) 38.16±2.8
pH 45 min 6.38±0.13
24 h 5.31±0.04
L* 45 min 50.64±1.0
24 h 56.23±2.0
a* 45 min 16.83±0.6
24 h 17.19±0.6
b* 45 min 3.89±0.2
24 h 7.02±0.4
Within stages, means with * differ (P < 0.05) and those with ** differ (P < 0.01)
Within the same line, # means the effects of dbcAMP in experiment 1 is differ fromthe control and db-cAMP-supplemented pigs in either
experiment except for the decreased a* value of the meat
in experiment 1 (Table 2).Effect of db-cAMP on biochemical indices in serum
Dietary supplementation with db-cAMP did not affect
the plasma concentrations of cholesterol, TG, FFA,
HDL, or LDL and the activity of lipase in either experi-
ment. Dietary supplementation with db-cAMP increased
the plasma concentrations of GH, IGF-I, T3, T4, and
cAMP in experiment 1 and strikingly decreased the
plasma concentration of leptin in experiment 2 (Table 3).Effect of db-cAMP on adipose tissue histology
Figure 1 showed that dietary supplementation with
15 mg/kg db-cAMP increased the number of adipocytes
per field and decreased the average diameter (P < 0.05)
of backfat cell by 4.0 % in experiment 1 and by 7.0 % in
experiment 2.nd meat quality in finishing pigs
Experiment 2

























Table 3 Effects of db-cAMP on serum biochemical indices and hormones in finishing pigs
Variable Experiment 1 Experiment 2
controls db cAMP controls db cAMP
Cholesterol (mmol/L) 2.45±0.08 2.34±0.11 1.96±0.11 2.08±0.06
TG (mmol/L) 0.36±0.04 0.38±0.04 0.28±0.02 0.29±0.03
Lipase (U/L) 48.3±6.6 62.1±13.5 42.7±3.6 69.9±15.2
FFA (□mol/L) 142.7±18.2 253.8±25.2 203.1±34.9 316.1±90.1
HDL (mmol/L) 0.54±0.08 0.58±0.06 0.71±0.05 0.77±0.03
LDL (mmol/L) 1.52±0.09 1.48±0.06 1.30±0.08 1.36±0.06
GH (ng/mL) 8.79±0.34 11.92±0.67* 8.87±0.24 9.26±0.65
IGF-1 (ng/mL) 337±23.5 431±24.2* 333±46.5 337±44.8
IGFBP3 (ng/mL) 63.8±5.7 86.6±10.0 67.6±12.4 68.4±13.2
T3 (ng/mL) 8.46±1.19 16.27±4.15* 11.35±1.17 11.37±1.65
T4 (ng/mL) 2.81±0.09 4.13±0.52* 3.41±0.19 3.42±0.35
Leptin (ng/mL) 1.44±0.44 0.99±0.23 7.15±1.45 2.10±0.22*
AD (ng/mL) 17.31±1.59 23.53±3.48 12.65±1.33 13.83±2.09
Insulin (ng/mL) 1.98±0.03 1.81±0.05 2.01±0.03 2.01±0.04
cAMP (pmol/mL) 73.69±3.69 127.36±28.8* 85.41±9.49 87.98±3.22
Within stages, means with * differ (P < 0.05)
TG, triglyceride; FFA, Free fatty acid; HDL, High-density lipoprotein; LDL, Low-density lipoprotein; IGFBP3, Insulin-like growth factor binding protein 3; T3,
Triiodothyronine; T4, Thyroxine; AD, Adrenaline
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pituitary gland, and liver of finishing pigs
Changes in relative transcript abundance of genes of
particular interest in the hypothalamus, pituitary, and
liver are presented in Table 4. Treatments with db-
cAMP increased the relative abundance of ADCYAP1,
GHRH, CRH, POMC, and PC1 (all P < 0.05) in the
hypothalamus in experiment 1. Similar increases also
occurred in pituitary abundance of GHRHR (P < 0.05),
GH (P < 0.01), and POMC (P < 0.05) and hepatic ex-
pression of GHR and IGF-1 (P < 0.01) in experiment
1. At the completion of experiment 2, db-cAMPA B
C D
Fig. 1 Left: Histological analysis of backfat in pigs at the end of experime
the end of experiment 2 (c controls; d db-cAMP). Means are for three rep
experiments. The control is 0 mg/kg db-cAMP, and the treatment group
from controltreatment increased the relative abundance of GHRH
(P < 0.05), CRH (P < 0.05), POMC (P < 0.01), and PC1
(P < 0.05) in hypothalamus, GH (P < 0.05) and POMC
(P < 0.05) in the pituitary gland, and hepatic expres-
sion of IGF-1 (P < 0.05). The effect of db-cAMP on
these gene expression was greater in experiment 1
than those in experiment 2 (P < 0.05), and db-cAMP
increased the gene expressions of GHRH, CRH, PC1,
PC2, GHRHR, GH, POMC, GHR and IGF-I by 173,
63, 142, 57, 32, 140, 131, 93, and 128 % in experi-
















nt 1 (a 0 mg/kg db-cAMP; b treated with 15 mg/kg db-cAMP) and at
licates. Right: The adipocyte diameter of the finishing pigs in both
is 15 mg/kg db-cAMP. ―*P < 0.05, **P < 0.01 differs significantly
Table 4 Effects of db-cAMP on relative gene expression in the hypothalamus, pituitary gland and liver of finishing pigs
Variable Experiment 1 Experiment 2
controls db cAMP controls db cAMP
Hypothalamus
ADCYAP1 0.56±0.02 0.78±0.02* 0.41±0.02 0.59±0.02
GHRH# 0.51±0.04 1.39±0.05** 0.38±0.05 0.72±0.08*
CRH# 0.94±0.03 1.53±0.06* 0.66±0.02 0.97±0.05*
POMC 0.81±0.01 1.00±0.01* 0.46±0.03 1.81±0.01**
PC1# 0.33±0.02 0.80±0.05* 0.64±0.04 0.99±0.01*
PC2# 0.35±0.02 0.55±0.03 0.71±0.02 0.82±0.01
Pituitary gland
GHRHR# 0.72±0.01 0.95±0.01* 0.45±0.01 0.46±0.01
GH# 0.50±0.02 1.20±0.01** 0.39±0.01 0.84±0.03*
CRHR 0.59±0.03 0.62±0.03 0.59±0.01 0.75±0.08
POMC# 0.49±0.02 1.13±0.01* 0.42±0.01 0.82±0.01*
TRHR 0.51±0.01 0.58±0.03 0.39±0.02 0.53±0.01
TSH 1.44±0.04 1.49±0.02 0.66±0.04 0.88±0.03
Liver
GHR# 0.55±0.01 1.06±0.03** 0.86±0.01 0.93±0.05
IGF-1# 0.50±0.01 1.14±0.01** 0.57±0.01 1.10±0.02*
Within stages, means with * differ (P < 0.05) and those with ** differ (P < 0.01).
Within the same line, # means the effects of dbcAMP in experiment 1 is differ from experiment 2.
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To better understand the mechanism of the effect of
dietary db-cAMP on fat deposition of the pigs, the back-
fat samples of experiment 1 were examined by microar-
rays and SAS analysis with thresholds for low probability
values (FDR) set at P < 0.05 and log-fold change >1.
Principal component analysis showed that differences
between the control and treated pigs had high similarity,
especially within the three control replicates.
Compared with the controls, the expression of 739
gene sets in treated animals changed significantly
(P < 0.05, fold change >2, or <0.5); 248 gene sets
were up-regulated (red), and 491 gene sets were
down-regulated (green). Of the 739, only 84 gene
sets have detailed comments and can be found in
public databases for pigs; 14 were up-regulated and
70 down-regulated (Table 5). The heatmap plot
(Fig. 2) showed that most of these genes (83 %) were
down-regulated in pigs supplemented with db-cAMP
compared with the controls.
Gene ontology analysis (SAS) showed that, compared
with the controls, differentially expressed genes in db-
cAMP supplemented pigs were significantly enriched in
the categories listed in Table 6. The highest enrichment
occurred in cell activation and immune functions, in-
cluding leukocyte functions. Pathway analysis of the 84
differentially expressed genes in pigs supplemented with
db-cAMP exposed the top five significant pathway mapsinvolving 30 genes, and all of these were down-regulated
(Fig. 3). The pathways, chemokine signaling, cell adhe-
sion molecules (CAMs), Toll-like receptor signaling,
cytokine-cytokine receptor interaction, antigen process-
ing and presentation, and type I diabetes mellitus are
consistent with the dietary supplementation causing a
significant change in immune or inflammatory status of
the adipose tissue.
Verification test
A selection of ten genes with relatively large change and
related to fat metabolism or cell signaling were chosen
to verify that their relative transcript abundance deter-
mined by the gene chips could be confirmed using real-
time, quantitative PCR. For nine genes (Fig. 4), there
was high correlation between the results of the mRNA
array and qPCR methods (the average R2 89 %).
Discussion
Consistent with others’ findings [39], the present dietary
supplementation with 15 mg/kg db-cAMP significantly
decreased the backfat thickness and fat percentage of
finishing pigs in both experiments while it did not affect
growth performance or meat quality in either experi-
ment, but Tian [36] found that db-cAMP stimulated the
growth performance of pigs. The present research also
showed that db-cAMP decreased the backfat thickness
and backfat percentage more marked in the earlier
Table 5 The differentially expressed genes in adipocytes of finishing pigs treated with db-cAMP
Gene ID Gene name Gene description P value Fold change
Up-regulated
396739 SAL1 salivary lipocalin 0.0025 22.14
407247 LHCGR luteinizing hormone/choriogonadotropin receptor 0.044 5.18
641359 SULT2A1 sulfotransferase family, cytosolic, 2A, dehydro- epiandrosterone
(DHEA)-preferring, member 1
0.0412 4.37
396597 STAR steroidogenic acute regulatory protein 0.0043 4.14
403149 CYP2A19 cytochrome P450 2A19 0.0096 3.40
397290 HOXD10A homeobox protein A10 0.0209 2.87
100124377 SBAB-707F1.10 solute carrier family 44, member 4 0.0353 2.58
397670 RH Rh protein 0.0444 2.56
733668 DIRAS3 DIRAS family, GTP-binding RAS-like 3 0.0036 2.41
397324 ACACA acetyl-Coenzyme A carboxylase alpha 0.0252 2.40
396861 LCN1 lipocalin 1 (tear prealbumin) 0.0062 2.29
100048933 ZFAND5 zinc finger, AN1-type domain 5 0.0113 2.25
100216478 TEF1 transcriptional enhancer factor 1 0.0200 2.19
414420 RPS28 ribosomal protein S28 0.0228 2.10
Down-regulated
100157574 LOC100157574 similar to family with sequence similarity 49, member B 0.0022 0.50
100156398 LOC100156398 mini-chromosome maintenance complex component 4 0.0333 0.50
100154512 LOC100154512 similar to tripartite motif-containing 38 0.046 0.49
397330 XPO1 exportin 1 (CRM1 homolog, yeast) 0.0159 0.49
396599 MCSF ALPHA macrophage colony stimulating factor alpha 0.0219 0.49
733579 LOC733579 tripartite motif protein TRIM5 0.0241 0.49
396655 STAT1 signal transducer and activator of transcription 1 0.0379 0.49
397177 DUOX1 dual oxidase 1 0.0234 0.48
100157208 LOC100157208 similar to Tectonic-3 0.0314 0.48
397222 MEOX2 mesenchyme homeobox 2 0.0095 0.48
100125540 SYK spleen tyrosine kinase 0.0183 0.48
397108 GP91-PHOX NADPH oxidase heavy chain subunit 0.0339 0.48
100154251 LOC100154251 similar to pleckstrin 2 0.0409 0.47
100048944 CPEB1 cytoplasmic polyadenylation element binding protein 1 0.0375 0.47
100158101 LOC100158101 similar to Rho GTPase-activating protein 30 0.0053 0.47
100048955 C5AR1 complement component 5a receptor 1 0.0121 0.47
100037274 TAF4B TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated
factor, 105 kDa
0.0089 0.46
397041 LGALS4 lectin, galactoside-binding, soluble, 4 0.0439 0.46
100049698 SNCAIP synuclein, alpha interacting protein 0.0078 0.45
595128 OAS2 2'-5'-oligoadenylate synthetase 2, 69/71 kDa 0.0401 0.453
397422 CCL2 chemokine (C-C motif) ligand 2 0.0181 0.45
387287 HCRTR1 hypocretin (orexin) receptor 1 0.0387 0.45
100124526 CD1D CD1d molecule 0.0189 0.45
397271 AIF1 allograft inflammatory factor 1 0.0132 0.44
396935 PCCB propionyl Coenzyme A carboxylase, beta polypeptide 0.0326 0.44
733649 TAP1 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) 0.0419 0.44
100156191 LOC100156191 zygote arrest 1-like protein 0.0402 0.44
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414912 PU.1 transcription factor PU.1 0.0044 0.43
100157355 LOC100157355 similar to spindle and KT associated 1 0.0325 0.43
404704 CD4 CD4 molecule 0.0029 0.43
100126851 SERPINB9 serpin peptidase inhibitor, clade B (ovalbumin), member 9 0.0464 0.42
396723 DDX58 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 0.0049 0.42
396943 ITGB2 integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) 0.0088 0.41
397141 NPL N-acetylneuraminate pyruvate lyase 0.0157 0.40
100037296 TLR7 toll-like receptor 7 0.0053 0.40
100048946 RNASEL Ribonuclease-L(2',5'-oligoisoadenylate-synthetase- dependent) 0.0105 0.40
100048958 GNA14 guanine nucleotide binding protein (G protein), alpha 14 0.0486 0.40
397441 CD86 CD86 molecule 0.0208 0.40
399500 IL6 interleukin 6 (interferon, beta 2) 0.0176 0.39
397590 PGHS-2 prostaglandin G/H synthase-2 0.024 0.38
100049665 KRT2 keratin 2 0.019 0.38
445460 C1QC complement component 1, q subcomponent, C chain 0.0045 0.38
100156254 LOC100156254 similar to Plastin-2 (L-plastin) (Lymphocyte cytosolic protein 1)
(LCP-1) (LC64P)
0.0435 0.38
100155269 LOC100155269 similar to lymphocyte antigen 9 0.0131 0.37
396900 AMCF-II alveolar macrophage-derived chemotactic factor-II 0.0494 0.37
404772 GEM GTP binding protein overexpressed in skeletal muscle 0.0291 0.36
397414 UF uteroferrin 0.0066 0.36
100153090 LOC100153090 similar to Cathepsin S 0.0411 0.36
414373 CCR3 chemokine (C-C motif) receptor 3 0.0179 0.3
100152784 LOC100152784 Vascular non-inflammatory molecule 3 precursor (Vanin-3) 0.0392 0.35
399541 TLR4 toll-like receptor 4 0.0474 0.35
606745 LOC606745 A2b adenosine receptor 0.0159 0.35
100049673 HPS3 Hermansky-Pudlak syndrome 3 0.038 0.35
396624 OX40L OX40L protein 0.0323 0.35
414374 CCR1 chemokine (C-C motif) receptor 1 0.0196 0.34
100152550 LOC100152550 similar to EF-hand domain (C-terminal) containing 1 0.038 0.34
503658 ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2 0.0481 0.33
397079 CECR1 cat eye syndrome chromosome region, candidate 1 0.0057 0.33
396880 IL8 interleukin 8 0.0091 0.32
396985 PLAU plasminogen activator 0.0474 0.32
100154994 LOC100154994 similar to serine proteinase inhibitor, clade B, member 10 0.0192 0.31
574057 PDCD1LG2 programmed cell death 1 ligand 2 0.0178 0.30
396726 FASLG Fas ligand (TNF superfamily, member 6) 0.0261 0.30
414904 CXCL2 chemokine (C-X-C motif) ligand 2 0.0093 0.30
100156373 LOC100156373 similar to villin 1 0.0067 0.28
397373 MYO7A myosin VIIA 0.0473 0.27
397102 AMBN ameloblastin 0.0329 0.19
100049669 GPNMB glycoprotein (transmembrane) nmb 0.0447 0.18
396662 CD2 CD2 molecule 0.0212 0.16
100135044 SBAB-591C4.5 MHC class II, DQ alpha 0.0027 0.09
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Fig. 2 Unsupervised hierarchical clustering analysis heatmap. a Control samples. b db-cAMP samples. Three replicates (each being pools from
three pigs) were analyzed for each group. Green: genes are down-regulated; red: genes are up-regulated
Ma et al. Genes & Nutrition  (2016) 11:17 Page 9 of 13stages than the later stages of finishing pigs, which im-
plied that supplementation of db-cAMP in the earlier
phase is better than the later phase of finishing pigs.
This additive also was found to improve carcass com-
position and increase longissimus area and leanTable 6 Significant GO of differentially expressed genes
GO ID Annotation Number Chan
GO:0001775 cell activation 15/150 (10)
GO:0050900 leukocyte migration 7/42 (16.67)
GO:0045321 leukocyte activation 12/123 (9.76)
GO:0042330 Taxis 9/76 (11.84)
GO:0002376 immune system process 24/410 (5.85)
GO:0001816 cytokine production 8/90 (8.89)
GO:0048583 regulation of response to stimulus 13/206 (6.31)
GO:0045058 T cell selection 3/16 (18.75)
GO:0009605 response to external stimulus 22/456 (4.82)
GO:0002682 regulation of immune system process 11/173 (6.36)
GO:0030029 actin filament-based process 10/154 (6.49)
GO:0006955 immune response 15/277 (5.42)
GO:0002520 immune system development 10/161 (6.21)
GO:0043900 regulation of multi-organism process 2/10 (20)percentages in other experiment [39]. In our experiment,
the longissimus area had a trend to increase after treated
with db-cAMP. The changes in adipocyte volume can be
used to estimate fat deposition in pigs [33] and adult rats
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Fig. 3 Pathway analysis of the differently expressed genes involved in several changed pathways of the db-cAMP treatment group compared
with the control group. Green: genes are down-regulated; red: genes are up-regulated
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adipocytes [38] in two different stages of finishing pigs,
which may be caused by inhibiting the proliferation of
preadipocytes and their differentiation [21], but the
mechanism of db-cAMP inhibiting the proliferation and
differentiation of preadipocytes is not illuminated yet.
Db-cAMP increasing the activities of lipolytic enzymes
[4] and inhibiting lipogenesis [21] was another reason
for the backfat thickness decreased. The present study
found that db-cAMP strikingly increased the plasma
concentrations of cAMP at the earlier phase of finishingFig. 4 The correlation coefficient of selected genes expressing level
by RT-qPCR and gene chip data. Vertical axis: the value of correlation
coefficient of the gene expression level by RT-qPCR and gene chip
data; horizontal axis: detected genespigs and decreased the plasma concentrations of leptin
at the later phase of finishing pigs, which verified the
finding of Maeda and Horiuchi [19].
Dietary db-cAMP clearly influenced fat metabolism re-
lated to hormone and genes in the hypothalamus and pi-
tuitary, most notably in the earlier phase of finishing
pigs; this is our novel founding. Both GH and its down-
stream peptide IGF-I and T3 and T4 were at higher con-
centrations in db-cAMP-treated pigs. Underlying these
changes, there were increases in several gene expression
level in the hypothalamus, pituitary, and liver in supple-
mented pigs. These included hypothalamic expression of
ADCYAP1 which activates adenylyl cyclase to increase
endogenous cAMP and stimulates secretion of GHRH
and CRH [3, 20], GHRH, CRH, POMC, and PC1 genes.
Supplementation with db-cAMP increased pituitary ex-
pression of GHRHR and GH and hepatic expression of
GHR and IGF-1, all of which indicated enhanced activity
of the GHRH-GH-IGF-1 axis. Some of these responses
were also evident, though of less magnitude, in the sec-
ond stage of finishing (day 170), consistent with higher
circulating concentrations of GH and IGF-1 in the sup-
plemented pigs. In experiment 1, supplemented pigs had
higher plasma concentrations of T3 and T4 though no
changes in pituitary expression of TRHR or TSH. The
thyroid hormones promote and, in cooperation with GH
and IGF-1, stimulate lipolysis [8, 37]. The findings de-
scribed here help explain that db-cAMP increased the
plasma contents of GH, IGF-1, T3, and T4 [6, 21, 39].
Dietary supplementation with db-cAMP also influenced
Ma et al. Genes & Nutrition  (2016) 11:17 Page 11 of 13the POMC axis with increasing the expression of POMC
both in hypothalamus and pituitary and CRH, PC1, and
PC2 in hypothalamus. This system is implicated in the
regulation of lipolysis and interactions between CRH
and POMC [2, 9, 28], which also was affected by the
dietary energy level and energy intake [22] and hydro-
lyzed by PC1 and PC2 [14, 34]. The changes detected
here suggest some involvement of the POMC system in
the effects of db-cAMP on lipid metabolism and fat ac-
cretion, and the possible mechanisms need to be further
researched.
Db-cAMP decreasing the backfat thickness and back-
fat percentage was verified by the 2 experiments using
different phases of finishing pigs in this present study,
and we found new mechanism of db-cAMP regulating
fat metabolism by mRNA array analysis that was db-
cAMP affected the immune/inflammatory reaction. As
the backfat thickness was obviously reduced by dietary
db-cAMP in the earlier phase of the finishing pigs, gene
expression in this tissue also was examined to expose
likely underlying mechanisms. Go analysis result showed
that db-cAMP inhibited the proliferation and differenti-
ation of fat cells and reduces the deposition of adipose
tissue through inhibiting adipose tissue cell activation,
cell tropism, leukocyte activation, migration, and the im-
mune system activation of the fattening pig. A relatively
low proportion (11 %) of the differentially expressed
gene sets was adequately documented, and of these, the
bulk (83 %) was down-regulated in db-cAMP-treated
pigs. It was of interest that the most striking changes
occurred, not in genes obviously related to lipid metab-
olism but in cohorts associated with immune/inflamma-
tory functions related to insulin sensitive or lipolysis.
There is increasing recognition that inflammatory reac-
tions in adipose tissue contribute to adiposity and ap-
pear to be linked to the metabolic syndrome and type I
diabetes. The differentially expressed genes identified
here were most obviously associated with pathways in-
cluding chemokine signaling, CAMs, antigen processing
and presentation, Toll-like receptor signaling, cancer,
cytokine-cytokine receptor interaction, and type I dia-
betes mellitus. The chemokine member CCL2 was highly
expressed in adipose tissue and contributed to the cells
becoming insulin resistant [10, 26] while CXCL2 (or
MIP-2), encoding macrophage inflammatory protein 2-
alpha (MIP2-alpha), was the main marker of inflamma-
tory reaction in metabolic syndrome [16, 35]. Another
cytokine IL-8 [18] was highly expressed in hypertrophied
adipocytes [1], and its inhibition decreased the likelihood
of obesity and type 2 diabetes [15]. Cytokine receptors
such as CCR1, CCR2, CCR3, and CCR5 also related to
insulin sensitivity [12], in turn closely connected with
the size of adipocytes [32]. These genes also were down-
regulated and stimulated lipolysis [23]. Although in thepresent experiment db-cAMP did not decrease the con-
centration of plasma insulin, it could decrease the insu-
lin sensitivity and stimulate the lipolysis, which reasons
need further research. The CAMs pathway included a
number of differentially expressed genes involved in
inflammatory infiltration, reactions, and responses [25].
Their down-regulation in pigs treated with db-cAMP
suggests diminished inflammatory sensitivity, perhaps
resulting in reduced fat accretion. This interpretation
was further supported by the diminished expression of
several genes involved in Toll-like receptor signaling
pathways critically involved in mediating inflammatory
responses including in adipocytes, some of which were
readily influenced by high-energy diets [27] and contrib-
uted to other pro-inflammatory factors secretion and in-
sulin resistance [13]. The differential expression of these
genes in backfat exposed by microarray analysis was, for
the most part, convincingly supported by quantitative
PCR measurements so they appear to be legitimate.Conclusions
The results obtained from these analyses indicated that
dietary supplementation of finishing pigs with db-cAMP
resulted in significantly reduced accumulation of sub-
cutaneous fat without changing growth performance or
carcass characteristics, apparently stemmed from sup-
pression of the inflammatory system within the adipose
tissue related to insulin sensitive or lipolysis. There were
additional systemic effects of treatment detected within
major endocrine GHRH-GH-IGF-1 axis and POMC
system, which are known to be involved in growth and
energy metabolism. Any reduction in excessive fat de-
position in finishing animals has economic and food
quality consequences, so improved understanding of the
underlying mechanisms allows exploring new strategies
for manipulating fat accretion. This study has contrib-
uted to explaining how dietary supplemental db-cAMP
provides a potential approach to achieving a more desir-
able animal product. In addition, this study illustrated
that db-cAMP regulated fat deposition through improv-
ing the immune system, which is of potential value to
dissect molecular pathways influencing fat deposition by
db-cAMP. It would be benefit for health of human clin-
ically used for weight loss.Abbreviations
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